Sequana Medical N.V.
BRU: SEQUA.BR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Brussels
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ian Crosbie
- Employees
- 48
- Headquarters
- Gent, Belgium
- IPO year
- 2019
- Market cap
- €47.8M
- Website
- https://www.sequanamedical.com
Loading SEQUA…
Loading profile data…Frequently asked questions about SEQUA
What does Sequana Medical N.V. (SEQUA.BR) do?
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct So...
Where does SEQUA.BR trade?
Sequana Medical N.V. (SEQUA.BR) trades on the Euronext Brussels.
What sector is SEQUA.BR in?
Sequana Medical N.V. (SEQUA.BR) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Sequana Medical N.V.?
Ian Crosbie is the chief executive officer of Sequana Medical N.V. (SEQUA.BR).
Where is Sequana Medical N.V. headquartered?
Sequana Medical N.V. is headquartered in Belgium.
Does SEQUA.BR pay a dividend?
Sequana Medical N.V. (SEQUA.BR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SEQUA.BR go public?
Sequana Medical N.V. (SEQUA.BR) completed its initial public offering in 2019.